State high court decisions keep COVID immunity in play but define scope
By
Kimberly Marselas
Aug 14, 2023
Connecticut’s highest court has offered a mixed ruling for a nursing home that sought dismissal of a wrongful death suit under a state provision limiting COVID-era liability. The rulings put senior...
New alert system makes sure seniors with hearing impairment receive emergency warnings loud and clear
By
Aaron Dorman
Jan 09, 2024
A new emergency alert system targets seniors who are hard of hearing, combining bright flashing lights and louder-than-normal alarms.
FDA approves new antibiotic for three indications
Apr 08, 2024
Zevtera is approved for S. aureus bloodstream infections, acute bacterial skin/skin structure infections and bacterial pneumonia.
People in the news, March 19
Mar 19, 2024
Appointments, promotions and other news at Ceca, the Florida Assisted Living Association, Kisco Senior Living, National Church Residences, Retirement Unlimited Inc., SAGE, the Smarter Service, Varsity...
Expanded use of Xolair to treat food allergies approved by the FDA
Feb 17, 2024
Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen.
Bill would close loophole on sexual predators working in senior living communities
By
Kimberly Bonvissuto
Mar 27, 2023
Legislation preventing sexual predators and human traffickers from working in senior living communities is working its way through the Oklahoma Legislature.
Managing cardiovascular disease risk factors may help preserve physical function in aging: study
By
Kimberly Bonvissuto
May 19, 2023
One-third of older adults experience physical limitations that lead to reduced mobility, disability, institutionalization and mortality. But managing risk factors for cardiovascular disease could help,...
First FDA-approved fecal-based treatment helps fight C. difficile
Dec 01, 2022
Rebyota is prepared from human stool donated by qualified individuals.
Initiative aims to help assisted living communities achieve excellence in person-centered care credential
By
Kimberly Bonvissuto
Jan 03, 2024
A research- and evidence-based initiative is underway to develop a process to help assisted living communities and other long-term care facilities achieve a new designation of excellence in person-centered...
FDA approves first RSV vaccine
May 03, 2023
Arexvy was ~82% effective in preventing RSV-induced lower respiratory tract infections in adults aged 60 or more years.